about
Genetic epidemiology of pelvic organ prolapse: a systematic reviewAdmixture mapping of pelvic organ prolapse in African Americans from the Women's Health Initiative Hormone Therapy trialLifetime risk of stress urinary incontinence or pelvic organ prolapse surgery.Hysterectomy rates in the United States, 2003.Trends and patterns of urodynamic studies in U.S. women, 2000-2012.Trends and Patterns of Urodynamic Studies in U.S. Males, 2000-2012.Genetic Determinants of Pelvic Organ Prolapse among African American and Hispanic Women in the Women's Health Initiative.Trends in the surgical management of stress urinary incontinence.Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012.Urinary, fecal, and dual incontinence in older U.S. AdultsCharacterizing the phenotype of advanced pelvic organ prolapse.Sling revision/removal for mesh erosion and urinary retention: long-term risk and predictors.Trends in use of surgical mesh for pelvic organ prolapseCost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.Phenotyping clinical disorders: lessons learned from pelvic organ prolapse.Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis.Management of Bartholin duct cysts and abscesses: a systematic review.Long-term outcomes of vaginal mesh versus native tissue repair for anterior vaginal wall prolapse.Prevalence and trends of symptomatic pelvic floor disorders in U.S. women.Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.Do urodynamic parameters predict persistent postoperative stress incontinence after midurethral sling? A systematic review.The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review.Computer modeling informs study design: vaginal estrogen to prevent mesh erosion after different routes of prolapse surgery.Changing trends in surgery for stress urinary incontinence.Clinical characteristics of women with familial pelvic floor disorders.Posterior tibial nerve stimulation for the treatment of fecal incontinence: a systematic evidence review.Cumulative Incidence of a Subsequent Surgery After Stress Urinary Incontinence and Pelvic Organ Prolapse Procedure.Urinary incontinence and hydration: A population-based analysis.Perioperative sexual interest in women with suspected gynecologic malignancies.A comparison of perineometer to brink score for assessment of pelvic floor muscle strength.Trends in Pharmacotherapy for Bladder Dysfunction Among Children in the United States, 2000 to 2013.Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050.Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a survey-based study.Sexual Health Before Treatment in Women with Suspected Gynecologic Malignancy.Internet Use Among Urogynecology Patients in North Carolina.The Evaluation of Baseline Physical Function and Cognition in Women Undergoing Pelvic Floor Surgery.Short-term outcomes of robotic sacrocolpopexy compared with abdominal sacrocolpopexy.Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.Factors associated with fecal incontinence in a nationally representative sample of diabetic women.
P50
Q26862451-5F9DD94D-1F6D-4FF3-AB04-9AC36DEC9022Q33765139-DF48806C-775E-4CDE-BC89-1E899AF613A5Q34240189-92344879-6318-473C-8A57-2E3DF05F6DF0Q34708653-3A14DB62-0AD1-4A92-9E0D-3B2379FCA102Q35142155-8872C25F-F241-4424-93B8-AED7AE4FD93CQ35702285-47641886-A43E-4307-B336-B33A6F4E83A0Q35834539-0C4BA1A0-8EAC-4B4F-8BDC-BEA262928B91Q35846651-24F33517-4FF8-4341-BBCE-23798B1C713FQ35925063-BBE69496-379B-4DD1-9E57-3F971000E37DQ36058830-162DBA34-6E21-4269-899A-DC5C48B00C75Q36420686-831B0306-BCB3-4B3A-99C5-356ACC043C1EQ36487195-6DC3A16F-40DF-495A-B5CE-9DF8356D8134Q36487616-E2DF8F35-CC99-46E4-8D48-98A433E52575Q36553799-0DE115B7-D2C9-453D-A6D9-2D6088EEF7E7Q36684956-19E4BDC5-8D12-415F-AF9E-8091199E0FBCQ36779995-6DFDBE27-65E1-489F-91CA-56EDDA46B42DQ37146280-E66351AA-D540-4E38-9EFE-0E5A84607B15Q37484346-A2E74130-11B3-4624-AE1F-AF0B3F6BDD8BQ37487582-CE42648B-148A-4D10-876C-BD6988015F5EQ37673910-2F9010C2-7C11-4CE5-B032-8D0A2F1084E6Q37737220-3FEDBEFF-B07F-438C-9549-3557AE70C784Q37991949-0764BBE1-BAEB-4F34-9B08-00847896FF3BQ37992885-ACCDFC23-FEAD-4130-8F09-DDBC7B495DBDQ38026781-53AB2674-05F4-449F-8D2B-650623C49FB9Q38123016-D2C1B0F9-0B39-42E0-9BF8-48E15791AFD4Q38263427-E8C6A6BD-7C3F-473E-AE10-3D54A512BCE2Q38480021-F2EFF5B2-382C-470B-B37A-32B9DD3CAB94Q38795807-8BAEC012-EBD4-407B-8B5D-36B7E15E5340Q38832139-2A9B1AAE-964B-46E1-919E-CFEB448ED288Q38836457-CD1D73C8-5FAA-486C-A1F8-5103EAEA95DCQ39717331-FD384B1E-4C93-47FE-AF7D-EC32EAA109EBQ39853460-D5CB05AF-8343-47CD-8084-A3B8CC770178Q39926533-F3FDE3F2-F05C-4C47-BDC6-2F319E1D4A16Q40000856-36C36B4B-D1E0-4939-A876-1F8CE852620CQ40075456-3D651F25-FE8B-4C93-8F0E-F8D7A4A27A0CQ40260762-CC2E69E6-C75C-44E9-9826-AFC3B17B9280Q40318714-0829EF3C-3709-4EE3-8074-730FCA8852E6Q40403861-60C9EFE9-6B1B-430D-B87B-DBCA3CE26963Q40562961-AECCADF2-67D1-4D32-BAC7-6218C8C93B68Q41740539-1106F9D3-5AFB-42BE-B124-68E9BCCB25D4
P50
description
researcher
@en
wetenschapper
@nl
name
Jennifer M Wu
@en
Jennifer M Wu
@nl
type
label
Jennifer M Wu
@en
Jennifer M Wu
@nl
prefLabel
Jennifer M Wu
@en
Jennifer M Wu
@nl
P106
P31
P496
0000-0002-3171-1054